Literature DB >> 24749973

The importance of genetic susceptibility in Dupuytren's disease.

K Becker1, S Tinschert, A Lienert, P E Bleuler, F Staub, A Meinel, J Rößler, W Wach, R Hoffmann, F Kühnel, H-G Damert, H-E Nick, R Spicher, W Lenze, M Langer, P Nürnberg, H C Hennies.   

Abstract

Dupuytren's disease (DD) is a progressive fibromatosis that causes the formation of nodules and cords in the palmar aponeurosis leading to flexion contracture of affected fingers. The etiopathogenesis is multifactorial with a strong genetic predisposition. It is the most frequent genetic disorder of connective tissues. We have collected clinical data from 736 unrelated individuals with DD who underwent surgical treatment from Germany and Switzerland. We evaluated a standardised questionnaire, assessed the importance of different risk factors and compared subgroups with and without positive family history. We found that family history clearly had the strongest influence on the age at first surgery compared to environmental factors, followed by male sex. Participants with a positive family history were on average 55.9 years of age at the first surgical intervention, 5.2 years younger than probands without known family history (p = 6.7 × 10(-8) ). The percentage of familial cases decreased with age of onset from 55% in the 40-49 years old to 17% at age 80 years or older. Further risk factors analysed were cigarettes, alcohol, diabetes, hypertension, and epilepsy. Our data pinpoint the importance of genetic susceptibility for DD, which has long been underestimated.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Dupuytren's contracture; Dupuytren's diathesis; Dupuytren's disease; complex genetics; connective tissue; myofibroblast; risk factors

Mesh:

Year:  2014        PMID: 24749973     DOI: 10.1111/cge.12410

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  8 in total

1.  Effect of nanoparticle-mediated delivery of SFRP4 siRNA for treating Dupuytren disease.

Authors:  Rujue Jin; Weigang Zhu; Jiajun Xu; Jianhui Gu; Aidong Deng
Journal:  Gene Ther       Date:  2022-03-28       Impact factor: 5.250

2.  The Role of Functional Polymorphisms in the Extracellular Matrix Modulation-Related Genes on Dupuytren's Contracture.

Authors:  Gediminas Samulenas; Ruta Insodaite; Edita Kunceviciene; Roberta Poceviciute; Lorena Masionyte; Urte Zitkeviciute; Loreta Pilipaityte; Alina Smalinskiene
Journal:  Genes (Basel)       Date:  2022-04-23       Impact factor: 4.141

3.  Metabolic factors and the risk of Dupuytren's disease: data from 30,000 individuals followed for over 20 years.

Authors:  Mattias Rydberg; Malin Zimmerman; Jin Persson Löfgren; Anders Gottsäter; Peter M Nilsson; Olle Melander; Lars B Dahlin
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

4.  Joint Stiffness Is Heritable and Associated with Fibrotic Conditions and Joint Replacement.

Authors:  Frances M Williams; Nicholas S Kalson; Stella M Fabiane; Derek A Mann; David J Deehan
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

5.  Meta-Analysis of Genome-Wide Association Studies and Network Analysis-Based Integration with Gene Expression Data Identify New Suggestive Loci and Unravel a Wnt-Centric Network Associated with Dupuytren's Disease.

Authors:  Kerstin Becker; Sabine Siegert; Mohammad Reza Toliat; Juanjiangmeng Du; Ramona Casper; Guido H Dolmans; Paul M Werker; Sigrid Tinschert; Andre Franke; Christian Gieger; Konstantin Strauch; Michael Nothnagel; Peter Nürnberg; Hans Christian Hennies
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

6.  A Genome-wide Association Study of Dupuytren Disease Reveals 17 Additional Variants Implicated in Fibrosis.

Authors:  Michael Ng; Dipti Thakkar; Lorraine Southam; Paul Werker; Roel Ophoff; Kerstin Becker; Michael Nothnagel; Andre Franke; Peter Nürnberg; Ana Isabel Espirito-Santo; David Izadi; Hans Christian Hennies; Jagdeep Nanchahal; Eleftheria Zeggini; Dominic Furniss
Journal:  Am J Hum Genet       Date:  2017-09-07       Impact factor: 11.025

7.  The worldwide prevalence of the Dupuytren disease: a comprehensive systematic review and meta-analysis.

Authors:  Nader Salari; Mohammadbagher Heydari; Masoud Hassanabadi; Mohsen Kazeminia; Nikzad Farshchian; Mehrdad Niaparast; Yousef Solaymaninasab; Masoud Mohammadi; Shamarina Shohaimi; Alireza Daneshkhah
Journal:  J Orthop Surg Res       Date:  2020-10-28       Impact factor: 2.359

8.  Evaluation of WNT Signaling Pathway Gene Variants WNT7B rs6519955, SFRP4 rs17171229 and RSPO2 rs611744 in Patients with Dupuytren's Contracture.

Authors:  Gediminas Samulėnas; Alina Smalinskienė; Rytis Rimdeika; Kęstutis Braziulis; Mantas Fomkinas; Rokas Paškevičius
Journal:  Genes (Basel)       Date:  2021-08-24       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.